PROGRAM

Click to Share

DAY ONE | MARCH 26, 2025

END

START

PROGRAM

SPEAKERS

Networking Breakfast

8:00 AM

9:45 AM

LION’S DEN
Early Stage Pitch Session with DNB//Back Bay Healthcare Innovation Accelerator companies

8:00 AM

9:45 AM

Jannik Grodt Schmidt, Head of Life Sciences, New York, Innovation Norway

Torgrim Isaksen, Healthcare Industry Specialist, DNB Bank, Norway

Presentations by GlucoSet//Induvita AS//Respinor//ExAC//Nordiq Products AS//Deepinsight AS//Nordic Brain Tech

Networking Break/Final Check-In

9:45 AM

10:00 AM

Jonathan Gertler
Chief Executive Officer, Managing Partner
Back Bay Life Science Advisors

Ted Jadick
President & Chief Executive Officer, DNB Markets Inc.

DNB//Back Bay Welcome

10:00 AM

10:15 AM

DAY ONE COMPANY PRESENTATIONS

Day One Moderators:

Jonathan Gertler and
Thomas Tangen, Head of Healthcare, North America, DNB Bank

Track Moderator: Vasilios Kofitsas, Managing Director, Investment Banking, Back Bay Life Science Advisors

MEDTECH TRACK

Cooper Companies

10:15 AM

10:30 AM

Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer

Embla Medical

10:30 AM

10:45 AM

G.Arna Sveinsdottir, Chief Financial Officer

Photocure

10:45 AM

11:00 AM

Dan Schneider, President and Chief Executive Officer

Bonesupport

11:00 AM

11:15 AM

Emil Billbäck, Chief Executive Officer

Networking Break in A&O Shearman Foyer

11:15 AM

11:30 AM

MEDTECH TRACK CONTINUES

Track Moderator: Devan Patel, Client Advisor, Healthcare, DNB Bank

Humacyte Global

11:30 AM

11:45 AM

Laura Niklason, Founder, President and Chief Executive Officer

Christoffer Rosenblad, Chief Executive Officer/Kristoffer Nordström, Chief Financial Officer

Xvivo Perfusion

11:45 AM

12:00 PM

Getinge

12:00 PM

12:15 PM

Mattias Perjos, President & Chief Executive Officer

NETWORKING LUNCH

12:15 PM

1:20 PM

Rachel L. Levine, MD
17th U.S. Assistant Secretary for Health

KEYNOTE - Conversations in Medicine and Public Health

1:30 PM

2:00 PM

PANEL: Medtech Opportunities in the New Capital & Acquisition Markets

2:00 PM

2:30 PM

Laura Niklason, Founder, President, Chief Executive Officer, Humacyte
Bruce Rosengard, Vice President, Global External Innovation, Medical Devices, Johnson & Johnson
Paul LaViolette, Managing Partner, Chief Executive Officer, SV Health Investors
Jesper Ingildsen, Senior Research Equity Analyst, Healthcare, DNB Markets
Moderator: Jonathan Gertler, Chief Executive Officer, Back Bay Life Science Advisors

Networking Break in A&O Shearman Foyer

2:30 PM

2:45 PM

Track Moderator:
Andreas Dirnagl, Client Advisor, Healthcare Corporate Banking, DNB Bank

BIOPHARMA ADVANCES TRACK

ALK-Abello

2:45 PM

3:00 PM

Per Plotnikof, VP, Corporate Communications, Investor Relations and Strategic Planning

BioArctic

3:00 PM

3:15 PM

Anders Martin-Löf, Chief Financial Officer

Novo Nordisk

3:15 PM

3:30 PM

Frederik Taylor Pitter, Director, North America Investor Relations

Cereno

3:30 PM

3:45 PM

Sten Sörensen, Chief Executive Officer

David Nathan, Director, Diabetes Center, Mass General Hospital
Sarah K. Emond, President, CEO, Institute for Clinical and Economic Review
Rune Majlund Dahl, Senior Equity Analyst, Healthcare, DNB Markets
Moderator: Steve Gauldie, Managing Director, Back Bay Life Science Advisors

PANEL: Novel Approaches in Metabolic Disease

3:45 PM

4:15 PM

DNB//Back Bay Closing Remarks

4:15 PM

4:30 PM

Jonathan Gertler and Ted Jadick

NAHC Toast Reception, A&O Shearman Foyer

4:30 PM

6:00 PM

Reception in celebration of NAHC companies – hosted by DNB//Back Bay and The Swedish Consulate General (this event is closed)

7:00 PM

9:00 PM

DAY TWO | MARCH 27, 2025

PROGRAM

START

END

SPEAKERS

Networking Breakfast

8:30 AM

9:00 AM

Anne Grabe
Global Head of Healthcare
DNB Bank

Jonathan Gertler
Managing Partner & CEO
Back Bay Life Science Advisors

DNB//Back Bay Welcome

9:00 AM

9:15 AM

DAY TWO COMPANY PRESENTATIONS

Day Two Moderators:

Anne Grabe, Global Head of Healthcare, DNB Bank and
Jonathan Gertler, CEO, Back Bay Life Science Advisors

RARE DISEASE TRACK

Track Moderator: Ellen Kettle, US Equity Sales, DNB Bank

Demant

9:15 AM

9:30 AM

Peter Pudselykke, Director, Head of Investor Relations

Francesco Maria Lavino, Chief Executive Officer

F2G

9:30 AM

9:45 AM

Gerard Tobin, Head of Investor Relations
Robert Jahr, Chief Commercial Officer

SOBI

9:45 AM

10:00 AM

Camurus

10:00 AM

10:15 AM

Fredrik Tiberg, Chief Executive Officer

Networking Break

10:15 AM

10:45 AM

Track Moderator: Christopher Leo, Managing Director, Back Bay Life Science Advisors

GN Group

10:45 AM

11:00 AM

Rune Sandager, Head of Investor Relations

NMD Pharma

11:00 AM

11:15 AM

Thomas Holm Pedersen, Chief Executive Officer

Track Moderator: Crystal Hsu, Associate Director, Investment Banking, Back Bay Life Science Advisors

Lundbeck

11:15 AM

11:30 AM

Palle Holm Olesen, Vice President, Investor Relations

HCRX

11:30 PM

11:45 PM

John Urquhart, Senior Managing Director

Panel: Capital Markets Update for Investors and Companies

11: 45 AM

12:30 PM

James Cirenza, Managing Director, DNB Markets Inc.
Carsten Borring, Head of Listings & Capital Markets, Denmark, Nasdaq Nordic
Thomas Hoftvedt, Managing Director, IBD, Head of Healthcare Coverage, DNB Markets
Sebastian Alexanderson, Head of Healthcare Investment Banking, Carnegie Investment Bank
Moderator: Greg Benning, Managing Director, Head of Investment Banking, Back Bay Life Science Advisors

Networking Lunch

12:30 PM

1:25 PM

KEYNOTE - Perspectives on the Development of a Disruptive Technology - the History and Future of Radiopharmaceuticals

1:30 PM

2:15 PM

Mary Anne Heino, Chairperson of the Board
Lantheus

ONCOLOGY TRACK

Track Moderator: Geir Hiller Holom, Senior Equity Analyst, Healthcare, DNB Markets

Pharmacosmos

2:15 PM

2:30 PM

Morten Faester, LifeScience Business Development & Licensing

Peter Nyquist, Head of Investor Relations

Elekta

2:30 PM

2:45 PM

Adcendo

2:45 PM

3:00 PM

Michael Pehl, Chief Executive Officer

Networking Break in A&O Shearman Foyer

3:00 PM

3:15 PM

PANEL: Oncology Technology Update for Investors

3:15 PM

3:45 PM

Geir Hiller Holom, Senior Equity Analyst, Healthcare, DNB Markets
Ketil Widerberg, General Manager, Oslo Cancer Cluster
Michaela Levin, VP, Business Development, Recursion
Moderator: Steve Gauldie, Managing Director, Back Bay Life Science Advisors

ONCOLOGY TRACK CONTINUES

Track Moderator: Peter Bak, Managing Director, Back Bay Life Science Advisors

Orion

3:45 PM

4:00 PM

René Lindell, Chief Financial Officer

enGene

4:00 PM

4:15 PM

Ryan Daws, Chief Financial Officer

Nanoform

4:15 PM

4:30 PM

Sergie Letser, Deputy CCO, Sr. VP Business Development
Henri von Haartman, Director of Investor Relations

DNB//Back Bay Closing Remarks

4:30 PM

4:45 PM

Jonathan Gertler, Ted Jadick, and Anne Grabe

NAHC Toast Reception, A&O Shearman Foyer

4:45 PM

6:00 PM

NAHC Closing Dinner (by invitation)

6:30 PM

9:30 PM

Speakers and time slots are subject to change so please check back for the latest program.

Thanks to the generous support of A&O Shearman, formerly Shearman & Sterling, the Nordic-American Healthcare Conference is held in the beautiful Shearman Conference Center at 599 Lexington Avenue, New York City. We are grateful for their contribution to this event. All guests must have confirmed registration to access the building.

All presentations are held in the Shearman Room unless otherwise noted in the program.

Request a Seat